Search Results 541-550 of 18318 for peptides

  1. Publications - Edwin A. Takahashi, M.D. - Mayo Clinic

    2015; 5:66-70. Takahashi EA, Moran SE, Hayashi MS, Inouye DS, Takanishi DM Jr, Yu M. Brain-type natriuretic peptide and right ventricular end-diastolic ...

  2. Breast Clinic - Clinical trials

    ... peptide receptor positive, estrogen receptor-positive, human epidermal growth receptor-2 negative metastatic breast cancer after progression on previous ...

  3. A Study to Evaluate Setmelanoitide to Treat Patients with Rare Genetic Disorders of Obesity - Mayo Clinic

    Note: Glucagon-like peptide-1 (GLP-1) receptor agonists may be used up to the dose approved for the treatment of diabetes mellitus (e.g., liraglutide up to ...

  4. Cardiovascular Outcomes Assessment of the MitraClip Therapy Percutaneous Therapy for High Surgical Risk Patients - Mayo Clinic

    ... peptide (BNP) ≥300 pg/ml or corrected n-Terminal pro- brain natriuretic peptide NT-proBNP ≥1500 pg/ml measured within 90 days prior to subject ...

  5. Cardiovascular Medicine - Doctors - Mayo Clinic

    Brain natriuretic peptide test, Heart failure, Cardiomyopathy, Pulmonary hypertension, Cardiac amyloidosis. Guy S. Reeder, M.D..

  6. A Study to investigate efficacy and safety of teplizumab compared with placebo in participants 1 to 25 years of age with Stage 3 Type 1 Diabetes - Mayo Clinic

    ... peptide at screening is acceptable for the inclusion; Female participants. Contraceptive use by women of childbearing potential (WOCBP) should be consistent ...

  7. An Extension Study For Long Term Assessment Of LY2951742 In Patients With Chronic Cluster Headaches - Mayo Clinic

    Current use or any prior exposure to any calcitonin-gene-related peptide (CGRP) antibody, any antibody to the CGRP receptor, or antibody to nerve growth factor ...

  8. William L. Hasler, M.D. - Doctors and Medical Staff - Mayo Clinic

    MemberStudy Section, Gastrointestinal Peptide Center, University of Michigan. 2001 - present. Grant ReviewerGastrointestinal Peptide Center, University of ...

  9. A Study Of LY2951742 For Patients With Episodic Cluster Headaches - Mayo Clinic

    Current use or any prior exposure to any calcitonin-gene-related peptide (CGRP) antibody, any antibody to the CGRP receptor, or antibody to nerve growth factor ...

  10. Trevogrumab or Trevogrumab with Garetosmab when taken with Semaglutide in patients with obesity. - Mayo Clinic

    The purpose of this study is to assess the effect of the addition of trevogrumab or trevogrumab with garetosmab to semaglutide on body weight and fat mass, ...